XML 46 R40.htm IDEA: XBRL DOCUMENT v3.22.2
Summary of Significant Accounting Policies - Narrative (Details)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2022
USD ($)
property
shares
Jun. 30, 2021
USD ($)
Jun. 30, 2022
USD ($)
property
shares
Jun. 30, 2021
USD ($)
Dec. 31, 2021
USD ($)
property
shares
Dec. 31, 2020
USD ($)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents [Abstract]            
Cash and cash equivalents $ 29,714 $ 19,796 $ 29,714 $ 19,796 $ 52,353  
Restricted cash 4,559 70,542 4,559 70,542 4,716  
Total cash, cash equivalents and restricted cash 34,273 90,338 34,273 90,338 $ 57,069 $ 118,765
Leases [Abstract]            
Real estate notes receivable, net 75,900   75,900      
Interest income $ 1,849 121 3,608 264    
Expected credit losses     $ 0      
Unconsolidated Joint Ventures [Abstract]            
Investment in unconsolidated joint ventures, ownership percentage 50.00%   50.00%   50.00%  
Investment in unconsolidated joint venture $ 62,070   $ 62,070   $ 62,834  
Income (loss) from unconsolidated joint venture $ 401 406 801 798    
Notes Receivable            
Leases [Abstract]            
Interest income     $ 3,200      
Disposal Group, Held-for-sale            
Leases [Abstract]            
Number of properties in portfolio | property 0   0   1  
Minimum            
Leases [Abstract]            
Lessor, term of contract 3 years   3 years      
Maximum            
Leases [Abstract]            
Lessor, term of contract 7 years   7 years      
Building and Building Improvements            
Real estate investments [Abstract]            
Depreciation expense $ 62,300 60,700 $ 124,600 121,900    
Healthcare Trust of America Holdings, LP (HTALP)            
Partners' Capital Notes [Abstract]            
Limited partner's capital, units issued (in shares) | shares 4,050,493   4,050,493   4,142,408  
Limited partner's capital, units outstanding (in shares) | shares 4,050,493   4,050,493   4,142,408  
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents [Abstract]            
Cash and cash equivalents $ 29,714   $ 29,714   $ 52,353  
Restricted cash 4,559   4,559   4,716  
Total cash, cash equivalents and restricted cash 34,273 90,338 34,273 90,338 57,069 $ 118,765
Leases [Abstract]            
Interest income 1,849 121 3,608 264    
Unconsolidated Joint Ventures [Abstract]            
Investment in unconsolidated joint venture 62,070   62,070   $ 62,834  
Income (loss) from unconsolidated joint venture $ 401 $ 406 $ 801 $ 798